HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J R Fischer Selected Research

Squamous Cell Carcinoma (Epidermoid Carcinoma)

4/2007[Successful individualized and targeted therapy of an NSCLC patient with Gefitinib based on a predictive assessment of the EGF-receptor mutation status].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J R Fischer Research Topics

Disease

14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 12/2001
8Neoplasms (Cancer)
01/2020 - 01/2000
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2011 - 12/2000
2Colorectal Neoplasms (Colorectal Cancer)
01/2001 - 04/2000
1Adenocarcinoma of Lung
01/2019
1Disease Progression
12/2017
1Neutropenia
10/2016
1Pneumothorax
08/2015
1Emphysema
08/2015
1Neoplasm Metastasis (Metastasis)
01/2015
1Lung Neoplasms (Lung Cancer)
02/2010
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2007
1Urinary Incontinence
01/2001
1Urge Urinary Incontinence (Urge Incontinence)
01/2001
1Renal Insufficiency (Renal Failure)
09/2000
1Gingivitis
09/2000
1Liver Failure
09/2000
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2000
1Carcinoma (Carcinomatosis)
04/2000
1Hyperinsulinism (Hyperinsulinemia)
01/2000
1Seizures (Absence Seizure)
01/2000
1Hypoglycemia (Reactive Hypoglycemia)
01/2000

Drug/Important Bio-Agent (IBA)

4Carboplatin (JM8)FDA LinkGeneric
10/2016 - 08/2011
3Interleukin-2 (IL2)IBA
09/2002 - 12/2000
2Tyrosine Kinase InhibitorsIBA
01/2019 - 05/2005
2Docetaxel (Taxotere)FDA Link
12/2017 - 03/2012
2ErbB Receptors (EGF Receptor)IBA
04/2014 - 04/2007
2Biological ProductsIBA
05/2012 - 04/2000
2Gefitinib (Iressa)FDA Link
04/2007 - 05/2005
2Interleukin-10 (Interleukin 10)IBA
09/2002 - 12/2001
2CytokinesIBA
09/2002 - 12/2001
1durvalumabIBA
01/2020
1tremelimumabIBA
01/2020
1Anaplastic Lymphoma KinaseIBA
01/2019
1AZD 6244IBA
12/2017
1Paclitaxel (Taxol)FDA LinkGeneric
10/2016
1Cisplatin (Platino)FDA LinkGeneric
10/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2014
1Cetuximab (Erbitux)FDA Link
03/2012
1Irinotecan (Camptosar)FDA LinkGeneric
08/2011
1Etoposide (VP 16)FDA LinkGeneric
08/2011
1Matrix Metalloproteinases (MMPs)IBA
02/2010
1Pemetrexed (MTA)FDA Link
05/2008
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2007
1Nonsense Codon (Nonsense Mutation)IBA
04/2007
1Galectins (Galectin)IBA
01/2001
1Imipramine (Janimine)FDA LinkGeneric
01/2001
1Messenger RNA (mRNA)IBA
01/2001
1Galectin 1 (LGALS1)IBA
01/2001
1Galectin 4 (LGALS4)IBA
01/2001
1Stanozolol (Winstrol)FDA Link
09/2000
1Lipoproteins (Lipoprotein)IBA
06/2000
1LipidsIBA
06/2000
1BilirubinIBA
06/2000
1Interleukin-6 (Interleukin 6)IBA
04/2000
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
04/2000
1Insulin (Novolin)FDA Link
01/2000
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2000

Therapy/Procedure

6Therapeutics
12/2017 - 07/2002
5Drug Therapy (Chemotherapy)
04/2014 - 12/2000
2Adjuvant Chemotherapy
01/2015 - 04/2013
1Chest Tubes (Chest Tube)
08/2015
1Pneumonectomy (Lung Volume Reduction)
01/2015
1Aftercare (After-Treatment)
01/2001